For press requests, please contact Jimmy Wyderko at jwyderko@economicliberties.us or 301-221-7778.


New Yorker: A Kansas Bookshop’s Fight with Amazon Is About More Than the Price of Books

March 12, 2021 — In a must-read feature that noted the influence of Research Director Matt Stoller’s book Goliath, The New Yorker illustrated how Amazon’s monopoly power is crushing independent bookstores across the country — and every other independent business that defines American downtowns.

“Investigate Insulin Now” Launches to Take Aim at Deadly Insulin Cartel

March 11, 2021 — Economic Liberties and a coalition of 42 advocates and economic justice organizations launched “Investigate Insulin Now,” an organizing campaign spotlighting how three companies — Eli Lilly, Novo Nordisk, and Sanofi — have colluded with one another to hike insulin prices in lockstep for years, and demanding policymakers at the Federal Trade Commission investigate and prosecute this deadly pharmaceutical cartel.

Economic Liberties Releases New Dataset Ahead of Senate Antitrust Hearing

March 11, 2021 — Economic Liberties released a new dataset that finds that more than 80 percent of corporations valued at more than $100 billion have faced antitrust scrutiny at some point in the last thirty years, including monopolization claims, merger challenges, price fixing suits, and no-poach suits. 

Politico Morning Tech: Facebook, Google brace for antitrust double-header in Congress

March 11, 2021 — In an exclusive feature, Politico’s Morning Tech covered Economic Liberties’ new database, which finds that 80% of corporations worth more than $100 billion have faced antitrust scrutiny.

Politico Pulse: The deadliest year in U.S. history

March 11, 2021 — Politico Pulse dove into Investigate Insulin Now, a new campaign Economic Liberties launched with 43 organizational partners and patient advocates to demand the Federal Trade Commission investigate and prosecute this deadly pharmaceutical cartel.